These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6662118)

  • 1. Comparative effects of nifedipine and diltiazem on vascular responses to norepinephrine and angiotensin II.
    Jover B; Dupont M; Casellas D; Mimran A
    Eur Heart J; 1983 Nov; 4 Suppl G():21-5. PubMed ID: 6662118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of omega-conotoxin on release of the adrenergic transmitter and the vasoconstrictor response to noradrenaline in the rat isolated kidney.
    el-Din MM; Malik KU
    Br J Pharmacol; 1988 Jun; 94(2):355-62. PubMed ID: 2456115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of nifedipine on vascular reactivity: study on the isolated and perfused rat kidney].
    Jover B; Caselas D; Dupont M; Mimran A
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():41-3. PubMed ID: 6810827
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversal of preexisting vasospasm in coronary artery conduits.
    Chanda J; Canver CC
    Ann Thorac Surg; 2001 Aug; 72(2):476-80. PubMed ID: 11515885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential inhibitory effect of nifedipine on angiotensin II-induced renal vasoconstriction.
    Imagawa J; Kusaba-Suzuki M; Satoh S
    Hypertension; 1986 Oct; 8(10):897-903. PubMed ID: 3531005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nifedipine, diltiazem and verapamil on the vasoconstrictor responses to norepinephrine and potassium ions in the rat mesenteric artery.
    Kondo K; Suzuki H; Okuno T; Suda M; Saruta T
    Arch Int Pharmacodyn Ther; 1980 Jun; 245(2):211-7. PubMed ID: 7406606
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcium antagonists block angiotensin II-mediated vasoconstriction in humans: comparison with their effect on phenylephrine-induced vasoconstriction.
    Andrawis NS; Craft N; Abernethy DR
    J Pharmacol Exp Ther; 1992 Jun; 261(3):879-84. PubMed ID: 1602392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y stimulates renal prostaglandin synthesis in the isolated rat kidney: contribution of Ca++ and calmodulin.
    el Din MM; Malik KU
    J Pharmacol Exp Ther; 1988 Aug; 246(2):479-84. PubMed ID: 3404443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of nifedipine on vascular reactivity: studies in the isolated perfused rat kidney.
    Jover B; Casellas D; Dupont M; Mimran A
    Eur Heart J; 1982 Oct; 3 Suppl C():15-7. PubMed ID: 7173233
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of diltiazem and manganese renal hemodynamics: studies in the isolated perfused rat kidney.
    Loutzenhiser R; Horton C; Epstein M
    Nephron; 1985; 39(4):382-8. PubMed ID: 3982581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verapamil, diltiazem and nifedipine block the depolarization-induced potentiation of norepinephrine contractions in rabbit aorta and porcine coronary arteries.
    Hondeghem LM; Ayad MJ; Robertson RM
    J Pharmacol Exp Ther; 1986 Dec; 239(3):808-13. PubMed ID: 3795042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal by the calcium antagonist nisoldipine of norepinephrine-induced reduction of GFR: evidence for preferential antagonism of preglomerular vasoconstriction.
    Loutzenhiser R; Epstein M; Horton C; Sonke P
    J Pharmacol Exp Ther; 1985 Feb; 232(2):382-7. PubMed ID: 3968640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasorelaxing and receptor binding properties of NZ-105, a novel dihydropyridine derivative, in isolated rabbit aorta.
    Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1991; 312():86-103. PubMed ID: 1663336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of nifedipine to prevent systemic and renal vasoconstrictor effects of endothelin.
    Madeddu P; Yang XP; Anania V; Troffa C; Pazzola A; Soro A; Manunta P; Tonolo G; Demontis MP; Varoni MV
    Am J Physiol; 1990 Aug; 259(2 Pt 2):F304-11. PubMed ID: 2201205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of endothelin and Ca++ entry blockers on renal circulation in anesthetized rabbits.
    Seino M; Abe K; Nushiro N; Omata K; Tsunoda K; Yoshinaga K; Kasai Y; Saito T; Sasao S
    Clin Exp Hypertens A; 1990; 12(2):205-13. PubMed ID: 2189604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II-mediated constriction of afferent and efferent arterioles involves T-type Ca2+ channel activation.
    Feng MG; Navar LG
    Am J Nephrol; 2004; 24(6):641-8. PubMed ID: 15627720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diltiazem and verapamil: functional antagonism of exogenous noradrenaline and angiotensin II in man.
    Magometschnigg D; Hörtnagl H; Rameis H
    Eur J Clin Pharmacol; 1984; 26(3):303-7. PubMed ID: 6376141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arguments in favor of postsynaptic antagonism by captopril (SQ 14,225) in the perfused kidney].
    Casellas D; Chevillard C; Jover B; Dupont M; Mimran A
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():51-4. PubMed ID: 6180695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nifedipine on the renal vascular responses and blood pressure responses to norepinephrine and angiotensin II in the anesthetized rabbit.
    Ito S; Seino M; Yasujima M; Abe K; Yoshinaga K
    Tohoku J Exp Med; 1983 May; 140(1):53-8. PubMed ID: 6868080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.